The AABB Foundation is pleased to announce the launch of its new Process Development Grant, which will provide funding to enhance the efficiency and effectiveness of blood- and biotherapies-related processes and operations in donor and patient care settings.
The AABB Foundation encourages professionals in the blood and biotherapies community to apply for the 2024 grant cycle. Applications will be accepted through Dec. 1, 2024.
Up to $100,000 is available from the AABB Foundation for a one-year project through the Process Development Grant.
The Process Development Grant supports improvements to business operations through the development, implementation, and outcomes analysis of innovative processes, techniques or technologies. Proposals that offer potential for widespread dissemination and adoption for the field will receive priority.
Examples of eligible focus areas include:
Applications are accepted from the US and internationally and applicants at any career level are welcome to apply.
An applicant must be a doctor (MD or PhD), medical technologist, transfusion medicine or biotherapies professional. Additionally, they must be affiliated with an institution that will serve as the administering organization if the grant is awarded. We particularly welcome applications from individuals associated with AABB-accredited facilities.
Application open | July 1, 2024 |
Application close | December 1, 2024 |
Funding notification | December 2024 |
Project begins | January 2025 |
Interim report due | July 2025 |
Final report due | March 2026 |
Interested individuals who have reviewed the AABB Foundation grant and application guidelines and have additional questions about this funding opportunity are invited to contact foundation@aabb.org for guidance. While the AABB Foundation is not able to provide feedback on proposal drafts, we are happy to answer questions by email.